Amandine Bernard

4PUBLICATIONS
9CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples medicine and treatmentsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 24, 2024
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.

Amandine Bernard, Mohamad Mroué, Sylvie Bourthoumieu

|Dec 23, 2022
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.

Amandine Bernard, Aurore Danigo, Mohamad Mroué

|Apr 23, 2022
Neuroprotective Effect of Ramipril Is Mediated by AT2 in a Mouse MODEL of Paclitaxel-Induced Peripheral Neuropathy.

Hichem Bouchenaki, Amandine Bernard, Flavien Bessaguet

|Nov 27, 2021
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.

Amandine Bernard, Aurore Danigo, Sylvie Bourthoumieu

Pageof 1